Qiagen NV
QGEN43.900USD
-0.030-0.07%
Fechamento 09/26, 16:00（ET）Cotações atrasadas em 15 min
9.52BValor de mercado
25.49P/L TTM
Mais detalhes de Empresa
Informações da empresa
Código da empresaQGEN
Nome da EmpresaQiagen NV
Data de listagemSep 01, 1996
CEOMr. Thierry Bernard
Número de funcionários5765
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 01
EndereçoHulsterweg 82
CidadeVENLO
Bolsa de valoresNYSE Consolidated
PaísNetherlands
Código postal5912 PL
Telefone31773556600
Sitehttps://www.qiagen.com/
Código da empresaQGEN
Data de listagemSep 01, 1996
CEOMr. Thierry Bernard
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert van Meurs
Mr. Bert van Meurs
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
Por EmpresaUSD
Nome
Receita
Proporção
Consumables and Related Revenues
435.06M
89.99%
Instrumentation
48.39M
10.01%
Por RegiãoUSD
Nome
Receita
Proporção
United States
232.85M
48.16%
Europe & Middle East & Africa
160.64M
33.23%
Asia, Pacific & Rest of the World
68.83M
14.24%
Other Americas
21.13M
4.37%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Consumables and Related Revenues
435.06M
89.99%
Instrumentation
48.39M
10.01%
Distribuição de ações
Atualizado em: qui, 11 de set
Atualizado em: qui, 11 de set
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Wellington Management Company, LLP
12.00%
MFS Investment Management
10.83%
BlackRock Institutional Trust Company, N.A.
9.47%
The Vanguard Group, Inc.
4.22%
T. Rowe Price International Ltd
2.74%
Outro
60.74%
Investidores
Investidores
Proporção
Wellington Management Company, LLP
12.00%
MFS Investment Management
10.83%
BlackRock Institutional Trust Company, N.A.
9.47%
The Vanguard Group, Inc.
4.22%
T. Rowe Price International Ltd
2.74%
Outro
60.74%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
47.08%
Investment Advisor
32.87%
Research Firm
4.24%
Sovereign Wealth Fund
1.64%
Pension Fund
1.60%
Hedge Fund
1.43%
Holding Company
1.17%
Bank and Trust
1.02%
Individual Investor
0.44%
Outro
8.50%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
996
189.55M
87.53%
+6.64M
2025Q1
1017
179.03M
82.67%
+27.58M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
2023Q1
1001
160.07M
74.44%
-9.45M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Wellington Management Company, LLP
24.44M
11.29%
+1.15M
+4.92%
Mar 31, 2025
MFS Investment Management
24.26M
11.2%
+24.26M
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.17M
9.31%
-350.47K
-1.71%
Jun 16, 2025
The Vanguard Group, Inc.
8.78M
4.06%
+245.16K
+2.87%
Mar 31, 2025
T. Rowe Price International Ltd
4.15M
1.92%
+4.01M
+2888.12%
Mar 31, 2025
EARNEST Partners, LLC
3.81M
1.76%
+3.81M
--
Mar 31, 2025
Amundi Asset Management, SAS
4.19M
1.94%
-516.05K
-10.96%
Mar 31, 2025
Swedbank Robur Fonder AB
3.06M
1.41%
+186.76K
+6.51%
May 31, 2025
Norges Bank Investment Management (NBIM)
3.96M
1.83%
-111.67K
-2.74%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de set
Atualizado em: sáb, 6 de set
Nome
Proporção
ROBO Global Healthcare Technology & Innovation ETF
1.62%
Zacks Small/Mid Cap ETF
0.71%
Fidelity International Multifactor ETF
0.4%
iShares ESG Advanced MSCI EAFE ETF
0.12%
iShares MSCI World ETF
0.01%
iShares Russell 2500 ETF
0%
SPDR MSCI EAFE StrategicFactors ETF
0%
iShares MSCI ACWI ex U.S. ETF
0%
Vanguard ESG International Stock ETF
0%
Global X Genomics & Biotechnology ETF
0%
Ver Mais
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.62%
Zacks Small/Mid Cap ETF
Proporção0.71%
Fidelity International Multifactor ETF
Proporção0.4%
iShares ESG Advanced MSCI EAFE ETF
Proporção0.12%
iShares MSCI World ETF
Proporção0.01%
iShares Russell 2500 ETF
Proporção0%
SPDR MSCI EAFE StrategicFactors ETF
Proporção0%
iShares MSCI ACWI ex U.S. ETF
Proporção0%
Vanguard ESG International Stock ETF
Proporção0%
Global X Genomics & Biotechnology ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Data
Tipo
Proporção
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
